Dosage and scheduling regimens for erythrocyte-sedimenting macromolecules.
D000707:Anaphylaxis / Q000139:chemically induced; D000818:Animals; D001704:Biopolymers / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D001782:Blood Donors; D001799:Blood Sedimentation; D002415:Cats; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005342:Fibrinolysis / Q000187:drug effects; D005780:Gelatin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage*; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000502:physiology; D046911:Macromolecular Substances / Q000494:pharmacology*; D051379:Mice; D008970:Molecular Weight; D009504:Neutrophils / Q000187:drug effects / Q000637:transplantation; D011817:Rabbits; D012306:Risk; D013213:Starch / Q000031:analogs & derivatives*; D013997:Time Factors; D014018:Tissue Distribution; D000516:alpha-Amylases / Q000097:blood
D001704:Biopolymers; D006895:Hydroxyethyl Starch Derivatives; D046911:Macromolecular Substances; D005780:Gelatin; D013213:Starch; D000516:alpha-Amylases